Featured Clinical Trial:
Adult asthma (product/compound: Lebrikizumab)
|
Do you have asthma? You may be eligible to participate in a national clinical research study located in Bellflower, California. Compensation available for qualified participants. We're looking for people over 18 years-old with stable asthma who are NOT taking inhaled corticosteroids. Qualified participants will receive study-related care, including physical exams, lab services, and asthma medications and injections. No insurance needed! No cost to you. The paid study is located in Bellflower, Calif. Enrollment is available on a first come, first serve basis. |
CALL TODAY: (888) 757-8881 ext 51(Se habla español!) |
ClinicAid Locations: Southern California – Bellflower
Status: Enrollment closed.
Condition: Adult Asthma
Product Name/Compound: Lebrikizumab
Full Study Title: A Study to Evaluate Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Not Taking Inhaled Corticosteroids (MOLLY)
Study Summary: This is a randomized, double-blind, placebo controlled, four-arm, dose-ranging study. The purpose is to evaluate the relationship between the dose of lebrikizumab and the response in terms of the efficacy, safety, and tolerability in patients with asthma who are not on inhaled steroids.
Eligible Participants:
Ages Eligible for Study: 18 Years to 65 Years
Genders Eligible for Study: Both
Inclusion (Eligible):
- Body weight ≥50 kg and ≤150 kg at Visit 1
- Chest radiograph within 12 months of Visit 1 without evidence of a clinically significant abnormality
- Stable asthma
Exclusion (Not Eligible):
- Asthma exacerbation during screening
- Known malignancy
- Known immunodeficiency
- Pre-existing lung disease other than asthma
- Uncontrolled clinically significant medical disease
- Current smoker
- History of substance abuse that may impair or risk the patient's full participation in the study, in the judgment of the investigator
- Prior allergic reaction to a monoclonal antibody
- Patients (men and women) of reproductive potential who are not willing to use contraception
- Pregnancy
Study Phase: Phase II (What are Phases?)
To receive information and updates for this trial:
Please contact us and mention the Trial ID below.
Trial ID (ClinicalTrials.gov): NCT00971035
<< Back to all ClinicAid clinical trials